Eli Lilly
LLY
$726.31
Share price
-2.63%
Change (1 day)
96.05%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Number of shares outstanding for Eli Lilly (LLY)
Number of shares outstanding as of April 2024 : 949,379,000
According to Eli Lilly's latest financial reports and stock price the company's current number of shares outstanding is 949,379,000. At the end of 2023 the company had 949,379,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Eli Lilly from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.94 B | -0.08% |
| 2022 | 0.95 B | -0.36% |
| 2021 | 0.95 B | -0.31% |
| 2020 | 0.95 B | -0.1% |
| 2019 | 0.95 B | -9.41% |
| 2018 | 1.05 B | 0.57% |
| 2017 | 1.05 B | -4.52% |
| 2016 | 1.10 B | -0.4% |
| 2015 | 1.10 B | -0.48% |
| 2014 | 1.11 B | -0.55% |
| 2013 | 1.11 B | -2.59% |
| 2012 | 1.14 B | 2.75% |
| 2011 | 1.11 B | 1.53% |
| 2010 | 1.09 B | 0.12% |
| 2009 | 1.09 B | 0.34% |
| 2008 | 1.09 B | 0.39% |
| 2007 | 1.08 B | -0.2% |
| 2006 | 1.09 B | 0.35% |
| 2005 | 1.08 B | 0.87% |
| 2004 | 1.07 B | -0.33% |
| 2003 | 1.08 B | 1.29% |
| 2002 | 1.06 B | -0.66% |
| 2001 | 1.07 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 153.56% | 🇺🇸 USA |
 Novartis NVS | 2,062,000,000 | 117.19% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,647,000,000 | 494.81% | 🇺🇸 USA |
 AbbVie ABBV | 1,765,940,733 | 86.01% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | -43.65% | 🇺🇸 USA |
 Sanofi SNY | 2,507,200,000 | 164.09% | 🇫🇷 France |
 Merck MRK | 2,554,166,667 | 169.04% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,057,000,000 | 116.67% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 226.32% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,028,000,000 | 113.61% | 🇬🇧 UK |